2-ethyl-6-methyl-1,3-benzoxazol-4-amine | 558476-79-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶唑类
• 英文名称: 2-ethyl-6-methyl-1,3-benzoxazol-4-amine
• 英文别名: 2-Ethyl-6-methylbenzo[d]oxazol-4-amine
• CAS: 558476-79-2
• 化学式: C₁₀H₁₂N₂O
• 分子量: 176.218
• InChiKey: NLHYUUOYJOCKAN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  52
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  (4E)-2-ethyl-6-methyl-6,7-dihydro-1,3-benzoxazol-4(5H)-one oxime 在 PPA 、 水 作用下， 反应 1.0h， 生成 2-ethyl-6-methyl-1,3-benzoxazol-4-amine
  参考文献：
  名称：

  Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors

  摘要：

  这项发明涉及将一般式(I)的化合物用作cdc25磷酸酶抑制剂，特别是cdc25-C磷酸酶和CD45磷酸酶，其中：W代表O或S。根据这项发明，一般式(I)的化合物特别可用于制备用于癌症治疗的药物。

  公开号：

  US20060040996A1

文献信息

• Product comprising at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
  申请人：Prevost Gregoire

  公开号：US20060281736A1

  公开（公告）日：2006-12-14

  A subject of the invention is a product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent for a therapeutic use which is simultaneous, separate or spread over time in the treatment of cancer. According to the invention, the other anti-cancer agent is preferably chosen from: analogues of DNA bases such as 5-fluorouracil; Type I and/or II topoisomerase inhibitors such as for example camptothecin and its analogues, doxorubicin or amsacrine; compounds interacting with the cell spindle such as for example paclitaxel (Taxol); compounds acting on the cytoskeleton such as vinblastine; inhibitors of the transduction of the signal passing through the heterotrimeric G proteins; prenyltransferase inhibitors, and in particular farnesyltransferase inhibitors; cyclin-dependent kinase (CDKs) inhibitors; alkylating agents such as cisplatin; antagonists of folic acid such as methotrexate; and inhibitors of the synthesis of DNA and cell division cell such as mitomycin C. A further subject of the invention is (1R)-1-[((2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl]-3-oxopropyl}dithio)methyl]-2-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8B)-yl]-2-oxoethylamine, or a pharmaceutically acceptable salt thereof, useful as an anticancer agent.

  本发明的一个主题是一种产品，包括至少一种Cdc25磷酸酶抑制剂与至少一种其他抗癌药物的组合，用于治疗癌症，治疗可以同时进行、分开进行或随时间推移进行。根据本发明，其他抗癌药物优选从以下选择：DNA碱基类似物，如5-氟尿嘧啶；I型和/或II型拓扑异构酶抑制剂，例如紫杉醇及其类似物、阿霉素或阿马曲辛；与细胞纺锤相互作用的化合物，例如紫杉醇（紫杉醇）；作用于细胞骨架的化合物，如长春碱；通过异三聚体G蛋白传递的信号的抑制剂；前尾转移酶抑制剂，特别是法尼基转移酶抑制剂；细胞周期蛋白依赖性激酶（CDKs）抑制剂；碱化剂，如顺铂；叶酸拮抗剂，如甲氨蝶呤；以及DNA合成和细胞分裂细胞的抑制剂，如丝裂霉素C。本发明的另一个主题是（1R）-1-[((2R)-2-氨基-3-[(8S)-8-(环己甲基)-2-苯基-5,6-二氢咪唑[1,2-a]吡嗪-7(8H)-基]-3-氧代丙基}二硫)甲基]-2-[(8S)-8-(环己甲基)-2-苯基-5,6-二氢咪唑[1,2-a]吡嗪-7(8B)-基]-2-氧代乙基胺，或其药学上可接受的盐，用作抗癌剂。
• [EN] BENZOTHIAZOLE- AND BENZOXAZOLE-4,7-DIONE DERIVATIVES AND THEIR USE AS CDC25 PHOSPHATASE INHIBITORS<br/>[FR] DERIVES DE BENZOTHIAZOLE- ET BENZOXAZOLE-4,7-DIONES ET LEUR UTILISATION COMME INHIBITEURS DE PHOSPHATASES
  申请人：SOD CONSEILS RECH APPLIC

  公开号：WO2003055868A1

  公开（公告）日：2003-07-10

  L'invention a pour objet l'utilisation en tant qu'inhibiteurs de phosphatases cdc25, et en particulier de phosphatase cdc25-C, et de la phosphatase CD45, des composés de formule générale (I) dans laquelle W représente O, ou S. Selon l'invention, les composés de formule générale (I) peuvent en particulier être utilisés pour préparer un médicament destiné à traiter le cancer.

  这项发明的目的是将通式(I)化合物作为cdc25磷酸酶抑制剂，特别是cdc25-C磷酸酶和CD45磷酸酶的抑制剂。根据本发明，通式(I)化合物特别适用于制备治疗癌症的药物。其中W代表O或S。
• Product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent
  申请人：Provost Gregoire

  公开号：US20090253685A1

  公开（公告）日：2009-10-08

  A subject of the invention is a product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent for a therapeutic use which is simultaneous, separate or spread over time in the treatment of cancer. According to the invention, the other anti-cancer agent is preferably chosen from: analogues of DNA bases such as 5-fluorouracil; Type I and/or II topoisomerase inhibitors such as for example camptothecin and its analogues, doxorubicin or armsacrine; compounds interacting with the cell spindle such as for example paclitaxel (Taxol); compounds acting on the cytoskeleton such as vinblastine; inhibitors of the transduction of the signal passing through the heterotrimeric G proteins; prenyltransferase inhibitors, and in particular farnesyltransferase inhibitors; cyclin-dependent kinase (CDKs) inhibitors; alkylating agents such as cisplatin; antagonists of folic acid such as methotrexate; and inhibitors of the synthesis of DNA and cell division cell such as mitomycin C. A further subject of the invention is (1R)-1-[((2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl]-3-oxopropyl}dithio)methyl]-2-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl]-2-oxoethylamine, or a pharmaceutically acceptable salt thereof, useful as an anticancer agent.

  本发明的一个主题是一种产品，其包含至少一种Cdc25磷酸酶抑制剂和至少一种其他抗癌药物的组合，用于治疗癌症的同时、分离或时间延长的治疗。根据本发明，其他抗癌药物优选从以下选择：DNA碱基类似物，例如5-氟尿嘧啶；I型和/或II型拓扑异构酶抑制剂，例如伯氨喹、多柔比星或阿姆沙曲；与细胞纺锤相互作用的化合物，例如紫杉醇（紫杉醇）；作用于细胞骨架的化合物，例如长春新碱；通过异源三聚体G蛋白传递信号的抑制剂；戊二烯基转移酶抑制剂，特别是戊二烯基转移酶抑制剂；细胞周期蛋白依赖性激酶（CDKs）抑制剂；碱基化剂，例如顺铂；叶酸拮抗剂，例如甲氨蝶呤；以及DNA合成和细胞分裂细胞的抑制剂，例如丝裂霉素C。本发明的另一个主题是（1R）-1-[（（2R）-2-氨基-3-[(8S)-8-（环己基甲基）-2-苯基-5,6-二氢咪唑[1,2-a]吡嗪-7（8H）-基]-3-氧代丙基}硫代）甲基]-2-[(8S)-8-（环己基甲基）-2-苯基-5,6-二氢咪唑[1,2-a]吡嗪-7（8H）-基]-2-氧代乙胺或其药学上可接受的盐，用作抗癌剂。
• BENZOTHIAZOLE- AND BENZOOXAZOLE-4,7-DIONE, DERIVATIVES AND THEIR USE AS CDC25 PHOSPHATE INHIBITORS
  申请人：Galcera Contour Marie-Odile

  公开号：US20070255063A1

  公开（公告）日：2007-11-01

  Heterocyclic dione compounds as disclosed in the specification, compositions thereof and methods for the use thereof, for the treatment of T cell-mediated conditions such as autoimmune diseases and organ graft rejection.

  本发明涉及杂环二酮化合物及其组合物和使用方法，用于治疗T细胞介导的疾病，如自身免疫疾病和器官移植排斥反应。
• BENZOOXAZOLE-4,7-DIONE, DERIVATIVES AND THEIR USE AS CDC25 PHOSPHATE INHIBITORS
  申请人：Galcera Contour Marie-Odile

  公开号：US20090131428A1

  公开（公告）日：2009-05-21

  The invention concerns the use as cdc25 phosphatase inhibitors, in particular cdc25-C phosphatase, and CD45 phosphatase, of compounds of general formula (I), wherein: W represents O or S. In accordance with the invention, the compounds of general formula (I) can in particular be used for preparing a medicine for cancer treatment.

  本发明涉及使用一般式（I）的化合物作为cdc25磷酸酶抑制剂，特别是cdc25-C磷酸酶和CD45磷酸酶的抑制剂，其中：W代表O或S。根据本发明，一般式（I）的化合物特别可用于制备治疗癌症的药物。